3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells
Authors:
- Fabrizio DamianoFabrizio Damiano
- Santo MarsiglianteSMSanto Marsigliante
- Gabriele V. GnoniGGGabriele V. Gnoni
- Luisa SiculellaLSLuisa Siculella
- 1 December 2013
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1831 (12) , 1679-1689
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Protein Kinase Cδ in Apoptosis: A Brief OverviewArchivum Immunologiae et Therapiae Experimentalis, 2012
- Reduced expression of FASN through SREBP‐1 down‐regulation is responsible for hypoxic cell death in HepG2 cellsJournal of Cellular Biochemistry, 2012
- SREBPs: metabolic integrators in physiology and metabolismTrends in Endocrinology & Metabolism, 2012
- 3,5,3′triiodo‐L‐thyronine induces SREBP‐1 expression by non‐genomic actions in human HEP G2 cellsJournal of Cellular Physiology, 2011
- Fatty Acid Synthase As a Potential Therapeutic Target in CancerFuture Oncology, 2010
- PI-3-K and AKT: Onto the mitochondria☆Advanced Drug Delivery Reviews, 2009
- p38 Mitogen-activated Protein Kinase Plays an Inhibitory Role in Hepatic LipogenesisJournal of Biological Chemistry, 2007
- Involvement of Akt in ER-to-Golgi Transport of SCAP/SREBP: A Link between a Key Cell Proliferative Pathway and Membrane SynthesisMolecular Biology of the Cell, 2006
- Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogeneAnnals of Oncology, 2005
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990